322 related articles for article (PubMed ID: 17113614)
1. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
Constantinou MA; Theocharis SE; Mikros E
Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
[TBL] [Abstract][Full Text] [Related]
2. Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
Aydin AF; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Güllüoğlu M; Uysal M; Koçak-Toker N
Peptides; 2010 Jan; 31(1):67-71. PubMed ID: 19958806
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
Lukivskaya O; Patsenker E; Lis R; Buko VU
Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
[TBL] [Abstract][Full Text] [Related]
4. Resistance of erythrocytes to lipid peroxidation in cirrhotic rats.
Oztezcan S; Balkan J; Dogru-Abbasoglu S; Cevikbas U; Aykaç-Toker G; Uysal M
Arch Med Res; 2005; 36(5):459-63. PubMed ID: 16099321
[TBL] [Abstract][Full Text] [Related]
5. Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1.
Kornek M; Raskopf E; Guetgemann I; Ocker M; Gerceker S; Gonzalez-Carmona MA; Rabe C; Sauerbruch T; Schmitz V
J Hepatol; 2006 Sep; 45(3):370-6. PubMed ID: 16780996
[TBL] [Abstract][Full Text] [Related]
6. [Protein expression profiles in a rat cirrhotic model induced by thioacetamide].
An JH; Seong J; Oh H; Kim W; Han KH; Paik YH
Korean J Hepatol; 2006 Mar; 12(1):93-102. PubMed ID: 16565610
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of chronic low-dose exposure of thioacetamide on rats based on NMR metabolic profiling.
Wei DD; Wang JS; Wang PR; Li MH; Yang MH; Kong LY
J Pharm Biomed Anal; 2014 Sep; 98():334-8. PubMed ID: 24996005
[TBL] [Abstract][Full Text] [Related]
8. Metabonomic deconvolution of embedded toxicity: application to thioacetamide hepato- and nephrotoxicity.
Waters NJ; Waterfield CJ; Farrant RD; Holmes E; Nicholson JK
Chem Res Toxicol; 2005 Apr; 18(4):639-54. PubMed ID: 15833024
[TBL] [Abstract][Full Text] [Related]
9. Deleterious effect of human umbilical cord blood mononuclear cell transplantation on thioacetamide-induced chronic liver damage in rats.
Alvarez-Mercado AI; García-Mediavilla MV; Sánchez-Campos S; Abadía F; Sáez-Lara MJ; Cabello-Donayre M; Gil A; González-Gallego J; Fontana L
Cell Transplant; 2009; 18(10):1069-79. PubMed ID: 19650975
[TBL] [Abstract][Full Text] [Related]
10. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration?
Haider S; Saleem S; Shameem S; Ahmed SP; Parveen T; Haleem DJ
Pol J Pharmacol; 2004; 56(1):73-8. PubMed ID: 15047980
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of C-Phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats.
Sathyasaikumar KV; Swapna I; Reddy PV; Murthy ChR; Roy KR; Dutta Gupta A; Senthilkumaran B; Reddanna P
J Neurol Sci; 2007 Jan; 252(1):67-75. PubMed ID: 17169376
[TBL] [Abstract][Full Text] [Related]
12. High voluntary alcohol consumption, in experimental liver cirrhosis is hardly responsive to opioid antagonist treatment.
Stasiak A; Fogel WA
J Physiol Pharmacol; 2008 Mar; 59(1):101-14. PubMed ID: 18441391
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of experimental cirrhosis in rats by HD-03.
Mitra SK; Udupa UV; Sheshadri SJ; Venkataranganna MV; Gopumadhavan S; Anturlikar SD
Acta Pharmacol Sin; 2000 Sep; 21(9):777-81. PubMed ID: 11501156
[TBL] [Abstract][Full Text] [Related]
14. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF
Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
[TBL] [Abstract][Full Text] [Related]
15. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.
Laleman W; Vander Elst I; Zeegers M; Servaes R; Libbrecht L; Roskams T; Fevery J; Nevens F
Eur J Clin Invest; 2006 Apr; 36(4):242-9. PubMed ID: 16620286
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy.
Wei L; Liao P; Wu H; Li X; Pei F; Li W; Wu Y
Toxicol Appl Pharmacol; 2009 Feb; 234(3):314-25. PubMed ID: 19073202
[TBL] [Abstract][Full Text] [Related]
17. Effects of zedoary turmeric oil on P450 activities in rats with liver cirrhosis induced by thioacetamide.
Cheng JJ; Yang NB; Wu L; Lin JL; Dai GX; Zhu JY
Int J Clin Exp Pathol; 2014; 7(11):7854-62. PubMed ID: 25550825
[TBL] [Abstract][Full Text] [Related]
18. Prevention of liver cirrhosis in rats by curcumin.
Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
[TBL] [Abstract][Full Text] [Related]
19. Beta-carotene attenuates experimentally induced liver cirrhosis in rats.
Wardi J; Reifen R; Aeed H; Zadel L; Avni Y; Bruck R
Isr Med Assoc J; 2001 Feb; 3(2):151-4. PubMed ID: 11344828
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity.
Kang JS; Wanibuchi H; Morimura K; Wongpoomchai R; Chusiri Y; Gonzalez FJ; Fukushima S
Toxicol Appl Pharmacol; 2008 May; 228(3):295-300. PubMed ID: 18374380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
